stockrow
Tuesday 3 November 2026
Export CNC’s income statement to Excel — free account
Centene Corporation
CNC Healthcare Healthcare Plans
Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024.
- Revenue
- +1.93%
- EPS
- +99.0%
- Free cash flow
- −437.4%
- Total debt
- −11.6%
Quarter to September 2026, against a year earlier
66.49
1.96
−2.86%
Follow CNC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
20.93 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.15 | 0.16 | 0.08 | 0.10 | |
P/FCF ratio |
7.79 | 3.54 | 2.27 | 4.70 | |
P/Operating CF |
(8.37) | 8.83 | 3.69 | 46.43 | |
P/B ratio |
1.38 | 1.40 | 0.75 | 1.01 | |
Price to Tangible BV |
4.14 | 4.17 | 2.56 | 4.35 | |
EV/Sales |
0.11 | 0.10 | 0.04 | 0.09 | |
EV/EBITDA |
10.14 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
4.80 | 2.13 | 1.10 | 3.41 | |
EV/FCF |
5.74 | 2.32 | 1.23 | 4.02 | |
Quick Ratio |
1.12 | 1.11 | 1.08 | 1.05 | |
Current Ratio |
1.16 | 1.15 | 1.12 | 1.10 | |
Net Debt/EBITDA |
1,005.50 | (7.31) | (3.41) | 2.06 | |
Debt/Assets |
19.60% | 19.40% | 20.17% | 22.67% | |
Debt/Equity |
0.70 | 0.71 | 0.76 | 0.87 | |
Asset Turnover |
2.53 | 2.40 | 2.36 | 2.45 | |
Operating CF/Net income |
51.68 | 3.29 | 2.83 | (0.40) | |
Capex/Depreciation |
(0.65) | (0.58) | (0.67) | (0.65) | |
Interest Coverage |
(2.06) | 7.83 | 11.35 | (10.39) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.39% | 5.79% | 6.80% | 6.78% | |
Intangible Assets out of Total Assets |
0.19 | 0.18 | 0.19 | 0.20 | |
Share Based Compensation of Revenue |
0.10% | 0.11% | 0.13% | 0.12% | |
Graham Net Nets |
(0.38) | (0.43) | (0.91) | (0.81) | |
Graham Number |
54.88 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
4.78% | (16.20%) | (40.07%) | (33.07%) | |
Free Cash Flow Yield |
12.85% | 28.24% | 44.15% | 21.29% | |
Revenue per Share |
102.49 | 108.50 | 101.50 | 100.84 | |
Operating CF per Share |
(7.42) | 7.27 | 8.87 | 0.89 | |
Capex per Share |
(0.39) | (0.35) | (0.41) | (0.43) | |
Free Cash Flow per Share |
(7.82) | 6.92 | 8.47 | 0.45 | |
Cash per Share |
47.73 | 54.79 | 48.25 | 41.21 | |
Shareholders Equity per Share |
45.09 | 45.83 | 43.70 | 40.63 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
45.09 | 45.83 | 43.70 | 40.63 | |
Free Cash Flow |
(3,863.00) | 3,416.00 | 4,166.00 | 224.00 | |
Working Capital |
6,393.00 | 5,926.00 | 4,944.00 | 3,652.00 | |
Capital Expenditures |
(194.00) | (174.00) | (200.00) | (213.00) | |
Net Current Asset Value |
(11,536.00) | (13,693.00) | (14,684.00) | (16,344.00) | |
EV/EBIT |
22.49 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
30.48 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
21,719.00 | 19,814.00 | 20,931.00 | 18,909.00 | |
Average Payables |
16,167.00 | 15,742.50 | 15,390.00 | 13,485.00 | |
Average Assets |
80,683.50 | 84,703.50 | 84,109.50 | 79,596.00 | |
Average Common Equity |
21,657.50 | 25,063.00 | 24,754.50 | 23,266.50 |
Columns are period end dates · fundamentals updated 2 Nov 2026